Melior Discovery
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
860 Springdale Dr Ste 500, Exton, Pennsy...Phone Number
(610) 280-0633Website
www.meliordiscovery.comRevenue
$11.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Melior Discovery
Melior Discovery specializes in preclinical drug development services, offering expert in vivo services and validated disease models to accelerate the drug discovery process. With a catalog of over 150 validated animal models across 14 therapeutic areas, they provide customized solutions for clients in the pharmaceutical industry. Since 2005, Melior has been recognized as a leader in phenotypic screening and drug repositioning, serving hundreds of companies with their innovative pharmacology platforms. Their commitment to delivering rapid and cost-effective data has established them as a trusted partner in the field of preclinical research.Explore more
Melior Discovery Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Melior Discovery your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Melior Discovery is spiking on competitors!
Click to see if Melior Discovery had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Melior Discovery has new funding data
Earning: See what the market has to say on Melior Discovery recently announced quarterly report
Product Launch: Get notified when Melior Discovery launches new products
Check if Melior Discovery has recently received funding, and reach out quickly before it becomes old news!
Melior Discovery, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Melior Discovery
Recommended Actions
Reach out to Masked Content who joined Melior Discovery as Masked Content
Find 2 more new buyers
Compare Similar Companies to Melior Discovery
Compare insights from companies similar to Melior Discovery, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Melior Discovery is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Melior Discovery is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Melior Discovery.
Melior Discovery financials insights
Gather financial insights about Melior Discovery, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$268K
Melior Discovery Tech Stack
A closer look at the technologies used by Melior Discovery
Most Recent Scoops
Lateral Move
Executive Move
Vivian(weina) Cong has been appointed as Vice President, Research and Development.
Left Company
Executive Move
Funding
Melior Discovery has received an SBA PPP loan in the amount of $268,100 from Mid Penn Bank resulting in the retention of 17 jobs.
Funding
Melior Discovery News & Media
Melior Is Selected as a Top 20 CRO by Pharma Tech Outlook
EXTON, Pa.--(BUSINESS WIRE)-- #CRO--Melior Discovery, Inc. (Melior) announced today that it has been selected as a top-20 CRO in the most recent edition of Pharma Tech Outlook magazine. This cover story article recognized Melior’s approach towards providing bespoke solutions in the preclinical in vivo pharmacology space and its pioneering achievements in phenotypic screening vis-à-vis its theraTRACE® platform. “I am very proud of the acknowledgment provided by the Pharma Tech editors on the striMelior Announces Substantial Additions to Its Management and Scientific Team
EXTON, Pa.--(BUSINESS WIRE)-- #canceranimalmodels--Melior Discovery, Inc. (Melior) announced today significant additions to its management organization. Joining the Melior organization will be Dr. Ken Kilgore (PhD, MBA) as Vice President of Pharmacology. Also joining Melior will be Dr. Hongyan Li as Director of Oncology. In addition, Melior veteran, Dr. Vivian Cong, will rise to the role of Vice President of Research and Development. Dr. Kilgore is a twenty-five-year industry veteran having initAdhera Therapeutics Expands Relationship with Melior Pharmaceuticals I, Adds NASH and Pulmonary Inflammation to Portfolio of Target Indications
Baton Rouge, LA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, today announces that the Company has extended its relationship with Melior Pharmaceuticals I, Inc. (“Melior Pharma 1”) through the addition of exclusive development rights for two more indications to the existing licensing agreement covering MLR-1023 (tolimidone), one of the world’s only potent and specific lyn kinase activators. As dMelior Pharmaceuticals Announces Execution of License Agreement for Armesocarb by Adhera Therapeutics
EXTON, Pa.--(BUSINESS WIRE)-- #Adhera--Melior Pharmaceuticals (Melior) announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . (OTCPK: ATRX; Adhera) for Melior’s Parkinson’s disease (PD) candidate, MLR-1019 (armesocarb). As with all of Melior’s drug candidates, MLR-1019 is a repositioned drug that has demonstrated safety and tolerability in previous clinical studies. Melior has uncovered a previously unreported therapeutic potential of MLR-1019 in PD. As such
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Melior Discovery
Sign Up For FreeTo access detailed company insights
Melior Discovery specializes in preclinical drug development services, offering expert in vivo services and validated disease models to accelerate the drug discovery process. With a catalog of over 150 validated animal models across 14 therapeutic areas, they provide customized solutions for clients in the pharmaceutical industry. Since 2005, Melio... Read More
